We previously reported that melatonin attenuated NAFLD in leptin-deficient mice and in hypercholesteremic Apo E mice by enhancing SIRT1 protein in hepatocytes [40,41]. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.